New hope for aggressive brain cancer: early trial tests tinostamustine
NCT ID NCT05432375
First seen Jan 03, 2026 · Last updated Apr 29, 2026 · Updated 23 times
Summary
This early-phase study tested a new drug called tinostamustine in 10 people with a fast-growing brain cancer (glioblastoma) that has a specific genetic marker (unmethylated MGMT). The goal was to see if the drug is safe and how the body processes it, given after standard treatment. While it aims to control the disease, it is not a cure, as ongoing monitoring and potential further treatment are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Universitario Ramón y Cajal, Madrid, Spain
Madrid, Spain
-
Hospital Universitario Vall d'Hebron, Barcelona, Spain
Barcelona, Spain
-
Kantonsspital
Sankt Gallen, Switzerland
-
South Texas Accelerated Research Therapeutics (START)
Madrid, Spain
-
University Hospital
Zurich, Switzerland
Conditions
Explore the condition pages connected to this study.